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Abstract
Background: Human immunodeficiency virus type 1 (HIV-1) induces neuronal dysfunction through host cellular
factors and viral proteins including viral protein R (Vpr) released from infected macrophages/microglia. Vpr is
important for infection of terminally differentiated cells such as macrophages. The objective of this study was to
assess the effect of Vpr in the context of infectious virus particles on neuronal death through proinflammatory
cytokines released from macrophages.
Methods: Monocyte-derived macrophages (MDM) were infected with either HIV-1 wild type (HIV-1wt), Vpr deleted
mutant (HIV-1ΔVpr) or mock. Cell lysates and culture supernatants from MDMs were analyzed for the expression
and release of proinflammatory cytokines by quantitative reverse transcription-PCR and enzyme-linked
immunosorbent assay respectively. Mitogen-activated protein kinases (MAPK) were analyzed in activated MDMs by
western blots. Further, the effect of Vpr on neuronal apoptosis was examined using primary neurons exposed to
culture supernatants from HIV-1wt, HIV-1ΔVpr or mock-infected MDMs by Annexin-V staining, MTT and
Caspase - GloW 3/7 assays. The role of interleukin (IL)-1β, IL-8 and tumor necrosis factor (TNF)-α on neuronal
apoptosis was also evaluated in the presence or absence of neutralizing antibodies against these cytokines.
Results: HIV-1ΔVpr-infected MDMs exhibited reduced infection over time and specifically a significant
downregulation of IL-1β, IL-8 and TNF-α at the transcriptional and/or protein levels compared to HIV-1wt-infected
cultures. This downregulation was due to impaired activation of p38 and stress-activated protein kinase
(SAPK)/c-Jun N-terminal kinase (JNK) in HIV-1ΔVpr-infected MDMs. The association of SAPK/JNK and p38 to IL-1β
and IL-8 production was confirmed by blocking MAPKs that prevented the elevation of IL-1β and IL-8 in HIV-1wt
more than in HIV-1ΔVpr-infected cultures. Supernatants from HIV-1ΔVpr-infected MDMs containing lower
concentrations of IL-1β, IL-8 and TNF-α as well as viral proteins showed a reduced neurotoxicity compared to
HIV-1wt-infected MDM supernatants. Reduction of neuronal death in the presence of anti-IL-1β and anti-IL-8
antibodies only in HIV-1wt-infected culture implies that the effect of Vpr on neuronal death is in part mediated
through released proinflammatory factors.
Conclusion: Collectively, these results demonstrate the ability of HIV-1ΔVpr to restrict neuronal apoptosis through
dysregulation of multiple proinflammatory cytokines in the infected target cells either directly or indirectly by
suppressing viral replication.
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Background
HIV-1 invades the central nervous system (CNS) during
early infection via infiltrating monocytes and lympho-
cytes that are infected in the periphery [1-4]. Studies in-
dicate that 40–50% of HIV-1 positive patients develop
some form of HIV-1 associated neurocognitive disorders
(HAND) [5-8]. Although productive HIV-1 infection of
primary neurons has not been demonstrated, it is well
accepted that neurons are affected by HIV-1 through in-
direct mechanisms. These include the release of proin-
flammatory cytokines/chemokines and viral proteins
from HIV-1-infected target cells. The proinflammatory
cytokines/chemokines and neurotoxins are released from
infected and/or exposed monocytes/macrophages [9-11].
Thus, activation of macrophages appears to be crucial
for the development of HAND.
Neuroinflammation is characterized by several proin-
flammatory events including the release of proinflamma-
tory cytokines such as IL-1β, -6, TNF-α, and chemokines
that drive this process [12]. IL-1β leads to NF-kB-
dependent transcription of proinflammatory cytokines
including TNF-α, IL-6 and interferon (IFN) [13]. TNF-α
which functions through caspase-dependent cascade, is
an important factor in various acute and chronic neuro-
degenerative disorders [14]. In the context of HIV-1-
induced neuropathogenesis, higher levels of TNF-α, IL-
1β, IL-6, IL-8, monocyte chemoattractant protein-1,
macrophage inflammatory protein-1 and CXCL10 are
observed in vivo and also in in vitro model systems
[15-17]. In subjects with HAND, levels of these neuroin-
flammatory factors are associated with higher viral load
in cerebrospinal fluid (CSF) [17-19]. In addition, HIV-1
gene products are also known to modulate the levels of
these cytokines in macrophages. In in vitro systems util-
izing macrophages as target cells, HIV-1 envelope pro-
tein gp120 has been shown to induce proinflammatory
cytokines production through p38, MAPK and phospha-
tidylinositol 3-kinase (PI3K) pathways [16,20]. Tat also
participates in HAND by stimulating cytokine/chemo-
kine networks in monocytes and macrophages [21].
HIV-1-encoded viral protein R (Vpr) has recently been
documented as having a substantial role in the develop-
ment of neuropathogenesis [22-25]. Recombinant Vpr
(rVpr) has been shown to modulate several chemokines at
the transcriptional level by regulating NF-κB-mediated
transcription [26,27]. It is important to note that several
of these studies have been carried out using recombinant
proteins at non-physiological concentrations. This has
prompted us to consider studies utilizing relevant infec-
tious HIV-1.
In this study, our goal was to evaluate whether Vpr dele-
tion can reduce neuronal death in the presence of other
neurotoxic viral proteins including gp120 and Tat. This
also documents indirectly a role for Vpr on neuronal
apoptosis in the presence of those viral proteins. Results
indicate that absence of Vpr decreased MDM infection
over time and that reduced the expression of selective
proinflammatory cytokines IL-1β, IL-8 and TNF-α in
MDMs at the transcript and/or protein levels. This reduc-
tion of proinflammatory cytokine production from MDMs
makes the Vpr deleted virus less neurotoxic compared to
its HIV-1 wild type (HIV-1wt) counterpart.
Materials and methods
Reagents
HIV-1 YU2wt and YU2ΔVpr plasmids were obtained from
Dr. Serge Benichou, France. Neural progenitor (NP) cells
were obtained from Millipore (Temecula, CA, USA), and
human recombinant IL-1β, IL-8 and TNF-α as well as neu-
tralizing antibodies against IL-1β, IL-8 and TNF-α were
purchased from R&D Systems (Minneapolis, MN, USA).
Extracellular signal-regulated kinase (ERK)1/2, p38 and
JNK inhibitors (PD98059, SB203580 and SP600125, re-
spectively) were purchased from Calbiochem (San Diego,
CA, USA).
Isolation and culture of MDMs
MDMs were generated from normal peripheral blood
mononuclear cells (PBMC). Heparinized blood samples
were purchased from Pittsburgh Blood Bank using appro-
priate Institutional Review Board approvals from University
of Pittsburgh. PBMCs were isolated by Ficoll-Hypaque gra-
dient centrifugation. CD14+ monocytes were purified by
positive selection using anti-CD14 monoclonal antibody-
coated magnetic microbeads (Miltenyi Biotech, Auburn,
CA, USA) and cultured as described previously [28]. To ob-
tain MDMs, CD14+ cells (0.5× 106 cells/ml) were cultured
in DMEM (GIBCO, Gaithersburg, MD, USA) containing
10% fetal bovine serum 2 mM L-glutamine (Cambrex,
Charles City, IA, USA) 1% penicillin-streptomycin (GIBCO,
Gaithersburg, MD), 1× 106 IU/ml GM-CSF and 1 pg/
ml M-CSF (R&D Systems, Minneapolis, MN, USA). Half
the volume of media was replaced every third day with
fresh media containing GM-CSF and M-CSF for 7–8 days
to differentiate them into MDMs.
Culture and differentiation of NP cells
NP cells at passage 2 to 6 were maintained in 35 mm
plates coated with 20 μg/ml poly-L-ornithine and recoated
with 5 μg/ml mouse laminin in ENStem-A neural expan-
sion media (Millipore, Temecula, CA, USA) along with
0.5% penicillin-streptomycin, 2 mM freshly added L-
glutamine and 20 ng/ml FGF-2. For neuronal differenti-
ation NP cells were centrifuged at 1000 rpm for 3 minutes
and the pellet was resuspended in ENStem-A neuronal
differentiation media (Millipore, Temecula, CA, USA).
The cell suspension was maintained in differentiation
media in 8-well chamber slides for up to 2–3 weeks.
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Virus preparation and characterization
HEK293T cells (2 × 106) were maintained in D-10 media
and transfected with 5 μg of HIV-1 proviral constructs
YU2wt and YU2ΔVpr using polyjet reagent (SignaGen
Laboratories, Gaithersburg, MD, USA) as per manufac-
turer’s instructions. Supernatants were collected 72
hours post-transfection, spun at 3000 rpm for 10 min-
utes and filtered through a 0.4 μm filter to remove cellu-
lar debris. All virus stocks were further concentrated by
ultracentrifugation at 22,000 rpm for 1 hour at 4°C and
were characterized for the presence of appropriate viral
proteins by western blot using anti-Gag and anti-Vpr
antibody (NIH, Germantown, MD, USA). Virus titer was
measured by p24 enzyme-linked immunosorbent assay
(ELISA) and the infectivity of the viruses was calculated
by standard TZM-bl assay.
Treatment of MDMs
Differentiated (7–8 day old) MDMs (2 × 106 cells/well)
were either infected with HIV-1wt or Vpr deleted mutant
(HIV-1ΔVpr) at a multiplicity of infection (MOI) of 0.1
for long-term infection or left untreated as a negative
control. Infected and control MDMs were maintained
for 21 days. Cell pellets and supernatants were collected
every 24 hours up to day 4 and every 4 days from day 8
to day 20 to monitor virus replication and cytokine pro-
duction. For assessment of MAPK signaling events,
infected MDMs were activated on respective days with
1 μg/ml of lipopolysaccharide (LPS) for 4 hours. For
analyzing cytokines in presence of MAPK inhibitors,
MDMs were pretreated with 10 μM of SB203580 (p38
inhibitor), or SP600125 (JNK inhibitor) or PD98059
(ERK1/2 inhibitor) for 2 hours followed by infection
with HIV-1wt or HIV-1ΔVpr at an MOI of 0.1 or mock.
Virus and mock-infected cultures treated with (dimethyl
sulfoxide) were used as controls.
Proinflammatory cytokine array profiling by quantitative
reverse transcription-PCR
Post exposure or infection time points, MDMs were
washed with cold phosphate-buffered saline (PBS) and
total RNA was extracted using the RNeasy mini kit
(Qiagen, Valencia CA, USA) according to the manufac-
turer’s protocol, with additional on-column DNase1 di-
gestion (RNase-free DNase kit, Qiagen, CA, USA). RNA
concentration was determined by spectrophotometry.
The integrity of RNA was assessed by 260/280 ratio and
analyzed by agarose gel electrophoresis. The RT² Profiler
PCR Array (SABiosciences, Valencia, CA, USA) was
used for mRNA profiling studies and the assay was per-
formed according to the manufacturer’s protocol. Briefly,
1 μg of total RNA extracted from mock, HIV-1wt or
HIV-1ΔVpr virus-infected MDMs was converted to
cDNA using a RNA first strand synthesis kit. The cDNA
product was used to perform the gene expression array
using a Taqman 7900HT machine. The data were nor-
malized for endogenous controls (included in the array)
and differential regulation of proinflammatory cytokines
(fold change) was analyzed from the Ct values from day
0 to day 20 using SABiosciences web-based tools. Genes
that are differentially regulated (+/− 2-fold) in infected
cultures were determined.
Measurement of cytokines by ELISA
Supernatants were collected at specific time points from
MDMs exposed/infected with HIV-1wt or HIV-1ΔVpr
viruses and kept at −80°C. The concentration of TNF-α
(BD Biosciences San Diego, CA, USA), IL-1β and IL-8
(R&D Systems, Minneapolis, MN, USA) were analyzed
in supernatants by ELISA following the manufacturer’s
protocol. The optical density (O.D) was determined for
each well using ELISA plate reader and the concentra-
tion of the cytokines were calculated from the standard
curve.
Immunofluorescence staining
Neurons were differentiated on poly L-ornithine and
mouse laminin coated 8-well chamber slides, fixed in 4%
paraformaldehyde for 15 minutes, permeabilized with
0.1% Triton-X-PBS for 15 minutes. The cells were rehy-
drated by 3 washes of PBS and 5 washes of 0.5% bovine
serum albumin (BSA). After blocking with 2% BSA for 1
hour the neurons were incubated with primary anti-
bodies against microtubule-associated protein 2 (MAP2)
(1:250), β-III tubulin (1:300) and glial fibrillary acidic
protein (GFAP) (1: 500) overnight at 4°C. The cells were
washed 5 times with 0.5% BSA and were further incu-
bated with Alexa Flour 488 goat anti-mouse-IgG, anti-
rabbit-Cy3. After 5 washes with 0.5% BSA and 5 times
with PBS the nuclei were stained with Hoechst 33342
(1 μg/ml) for 30 seconds. The slides were mounted and
staining was checked under microscope.
Treatment of neurons with specific neutralizing
antibodies against proinflammatory cytokines
Primary neurons (3 × 04 cells/well) were exposed to
supernatants from HIV-1wt, HIV-1ΔVpr and mock-
infected MDMs (10% of the volume of the total media)
collected on day 8 or day 12 as well as recombinant IL-
1β (10 ng/ml), IL-8 (10 ng/ml) and TNF-α (100 ng/ml).
The cells were replenished with media containing
neutralizing antibodies against IL-1β (5 μg/ml), IL-8
(5 μg/ml) and TNF-α (10 μg/ml) (R&D Systems, Minne-
apolis, MN, USA). The neuronal apoptosis was mea-
sured 24–48 hours after infection.
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Annexin-V FITC staining
Analysis of apoptosis was carried out using the apoptosis
detection kit (BD Biosciences, San Diego, CA, USA) as
per the manufacturer’s instructions. Briefly, neurons
were exposed to HIV-1wt, HIV-1ΔVpr, mock-infected
MDM supernatants (10% v/v) and recombinant cyto-
kines for 24–48 hours. To detect apoptosis, infected
media were removed, the cells were washed twice with
1X PBS and then once with 1X Annexin V binding buf-
fer. Neurons were stained with Annexin V-FITC diluted
(1:10) in 1X binding buffer for 15 minutes at room
temperature in the dark, then washed once with 1X
binding buffer. The apoptotic neurons (%) were quanti-
fied by nuclei staining with Hoechst 33342 and analyzed
by microscopy. Neuronal apoptosis was calculated from
the percentage of cells stained with Annexin-V.
MTT assay
The effect of HIV-1Vpr-mediated proinflammatory fac-
tors on inducing neuronal death was also assessed using
MTT assay. Briefly, 1 × 105 primary neurons in each well
of a 96-well plate (in triplicate) were exposed with the
supernatants from mock, HIV-1wt and HIV-1ΔVpr-
infected MDMs (10% v/v) as well as recombinant cyto-
kines and incubated at 37°C in 5% CO2 for 24 hours.
The neurons were incubated with 1.2 mM of MTT solu-
tion for 4 hours at 37°C. The formazan crystals were
solubilized in 100 μl DMSO and by shaking the plate for
10 minutes. The absorbance was measured at 540 nm.
Mock-infected cells produced the highest O.D reflecting
the highest cell survival and cells treated with DMSO
were used as a negative control.
Caspase - GloW 3/7 assay
Caspase-3/7 activities were measured using Caspase-
GloW 3/7 Assay kit (Promega, Madison, WI, USA)
according to manufacturer’s instructions. Briefly, 5 × 104
primary neurons differentiated in each well of a 96-well
plate were exposed to supernatants of mock, HIV-1wt
and HIV-1ΔVpr-infected MDMs (10% v/v) for 24–48
hours. The cells were incubated for 1 hour at 37°C with
equal volume of Caspase-GloW 3/7 reagent to the vol-
ume of culture medium. The luminescence that is pro-
portional to caspase 3/7 activities was determined by
luminometer. A negative control consisting of cells with-
out MDM supernatant treatment was also included in
each assay.
Western blot
MDMs were washed twice with cold PBS and lysed in
RIPA buffer containing 50 mM Tris (pH 7.5), 150 mM
NaCl, 1% Triton-X100, 1 mM sodium orthovanadate,
10 mM sodium fluoride, 1.0 mM phenylmethyl-sulfonyl-
fluoride, 0.05% deoxycholate, 10% sodium dodecyl sulfate
(SDS), 0.07 trypsin inhibitor units/ml aprotinin, and prote-
ase inhibitors Leupeptin, Chymostatin, and Pepstatin
(1 μg/ml; Sigma). Cell lysates were clarified by centrifuga-
tion and total cell lysates (50 μg) were separated on a
SDS-PAGE gel, transferred, and the expression of proteins
were detected with anti-ERK1/2, anti-p-38 (total and ac-
tive; Cell Signaling Technology, Beverly, CA, USA), anti-
SAPK/JNK (Cell Signaling Technology, Beverly, CA,
USA), and anti-poly ADP-ribose polymerases (PARP; total
and cleaved; Cell Signaling, Beverly, CA, USA). Anti-
tubulin (NeoMarkers, Fremont, CA, USA) was used as
loading control. Blots were developed using ECL kit
(Pierce, Richmond, Illinois, USA). The results were ana-
lyzed and densitometric measurements were normalized
against total proteins or α-tubulin expression levels.
Statistical analysis
Results were expressed as mean± SEM for three experi-
ments. The data were analyzed using student’s t-test for
normally distributed data with equal variances and
P < 0.05 was considered significant. The immunoblotting
images were quantified using Image J software. For qRT-
PCR data analysis SABiosciences web-based software
was used. Promoter analysis was performed using Gen-
ome TraFac software (http://genometrafac.cchmc.org/
genome-trafac) as described [29].
Results
Characterization of viruses and replication kinetics of HIV-
1wt and HIV-1Δvpr in MDMs
HIV-1 YU2wt and YU2ΔVpr were produced through
transfection of respective proviral DNAs into HEK293T
cells. Supernatants were collected and virus particles in
the culture supernatants were characterized for the pres-
ence of p24 and Vpr by western blot using specific anti-
bodies (Figure 1A). Comparable expression level of Gag-
p24 was found in both HIV-1wt and HIV-1ΔVpr viruses,
whereas, presence of Vpr was observed only in HIV-1wt
as expected.
For virus replication studies, MDMs from multiple
normal healthy donors (N = 6) were infected with an
equal amount of HIV-1wt or HIV-1ΔVpr according to
standard protocols described in Methods. To assess virus
replication kinetics, supernatants at different time points
were collected and virus titer was measured by p24
ELISA (Figure 1B). Results indicate that viral infection
increased with time in all donors. Interestingly, removal
of Vpr suppressed but not completely abolished HIV-1
replication in MDMs over time and this pattern is con-
sistent in all tested donors suggesting that HIV-1 Vpr
plays a significant role in MDM infection although it is
not absolutely essential for infection.
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Differential regulation of proinflammatory factors in HIV-
1wt, HIV-1Δvpr and mock-infected MDMs
It has been suggested that HIV-1-infected macrophages/
microglia-mediated neuronal dysfunction are in part via
proinflammatory factors/neurotoxins released by these
cells [30]. Several viral proteins including Env, Nef, Tat
and Vpr have been implicated in inducing proinflamma-
tory responses in macrophages [31]. To better under-
stand whether absence of Vpr causes any significant
difference in proinflammatory cytokine expression in
MDMs, we used normal donor derived MDMs infected
with HIV-1wt or HIV-1ΔVpr or mock for focused qRT-
PCR array. Compared to mock/control MDMs, HIV-1wt-
infected cells showed an enhanced expression of a num-
ber of cytokines and proinflammatory genes at different
time points (Table 1). Among the upregulated genes, IL-
1β and IL-8 exhibited a higher fold increase over mock
treated, whereas, TNF-α, IL-22, IL-10 and C3 showed a
modest increase in multiple donors (Table 1). During
the infection phase (5–20 days post infection) IL-1β, IL-
8 and C3 remained at a high level, whereas, other proin-
flammatory factors did not show any difference between
infected and uninfected controls.
To examine the effect of Vpr mutation on differential
gene expression in MDMs, HIV-1ΔVpr-infected culture
was compared with mock-infected cultures (Table 2).
Comparative analyses indicate that IL-1α, IL-1β, IL-8,
TNF-α, C3 and BCL6 were upregulated during early
time points (1–4 days) and were either downregulated
or did not show significant difference during later infec-
tion phase (5–20 days post infection). Less infectivity of
HIV-1ΔVpr virus in MDMs was supported by Table 2
Figure 1 Characterization and kinetics of HIV-1wt and HIV-1ΔVpr virus particles. (a) HEK 293 T cells were transfected with 5 μg of HIV-1
YU2wt and HIV-1 YU2ΔVpr plasmids. Viruses collected after 72 hours were filtered, concentrated by ultracentrifugation and western blot analysis
was performed for Gag and Vpr. (b) Productive infection of MDMs by viruses. MDMs were infected with HIV-1wt and HIV-1ΔVpr viruses at an MOI
of 0.1 or left untreated as negative control (NT). The release of virus particles from infected MDM culture was monitored by p24 ELISA using the
supernatants on days as indicated. The data are representatives of one of six independent experiments.
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because the initial differences observed on the first day
of culture are not carried through at further time points
although expression of few cytokines such as TNF-α, IL-
5 and IL-10 was sporadically regulated during the infec-
tion phase.
To delineate the specific effect of Vpr mutation in
presence of other viral proteins in context of HIV-1wt,
cytokine array results were compared between HIV-1wt
and HIV-1ΔVpr-infected MDMs (Table 3). Absence of
Vpr downregulated several proinflammatory molecules
such as IL-1α, IL-1β, IL-8 compared to HIV-1wt-infected
culture in infection phase, suggest that Vpr could have a
specific effect in activating proinflammatory factors, ei-
ther directly or through enhanced viral replication. IL-1β
and IL-8 were downregulated 4 days post infection and
remained low in the absence of Vpr.
To determine the most significantly regulated proin-
flammatory genes, the gene array data were reanalyzed
including all time points. Table 4 shows the proinflam-
matory genes that were differentially regulated in HIV-
1ΔVpr-infected MDMs compared to HIV-1wt combining
all time points. Results indicate that Vpr mutant virus
has a significant effect on downregulation of proinflam-
matory IL-1β and IL-8 in MDMs compared to HIV-1wt.
To further examine whether the differences noted with
proinflammatory cytokines at the transcriptional level
were also present at the protein levels, the supernatants
from HIV-1wt, HIV-1ΔVpr and mock-treated MDMs
from different time points were analyzed for IL-1β, IL-8
and TNF-α by ELISA. TNF-α was included for this study
because it has already been indicated as a known proin-
flammatory marker [14]. Consistent with the data on
Table 1 Differentially regulated inflammatory genes in
MDMs infected with HIV-1wt compared to mock/
uninfected (N=6)
Genes Day1 Day2 Day3 Day4 Day8 Day12 Day16 Day20
CD40LG - - - - 2.00 2.32 - 3.02
IFNA2 −2.70 - −2.25 - - - −2.04 -
IL10 3.596 - - - - - - 3.224
IL13 - - - - - - 2.215 -
IL1A 9.54 5.83 - - - 2.63 - -
IL1B 55.89 31.59 3.58 2.31 2.19 7.97 8.09 9.87
IL1F5 - - - −3.40 - 2.135 - −4.52
IL1F6 - −2.015 −2.94 - - - - −2.38
IL1F8 - −2.42 - −4.49 - - - −18.56
IL1F9 12.81 4.194 - - 3.76 - - 2.54
IL22 2.237 - −3.18 −2.12 - - - 2.334
IL5 - −2.13 - 2.31 5.41 2.81 -
IL8 20.63 11.56 3.146 2.16 2.08 3.22 3.88 6.698
IL9 −2.46 −3.445 - - - 2.02 - −7.88
LTA - - - - 4.74 3.19 -
SPP1 - - - −2.26 −2.21 −2.77 −2.43
TNF 3.13 - - −2.69 - - - 2.20
IL10RA - 2.03 - - - - - -
IL9R - - −2.27 - - - - -
IL5RA - - −4.33 - - - - -
BCL6 3.31 2.50 - - - - 2.01 3.185
C3 8.49 7.86 3.35 2.52 3.16 2.03 - 8.90
C4A - - - - 3.49 - - 2.35
CEBPB - - - - - - - 3.59
CRP - - - - - - −2.27 -
IL1R1 - - 2.14 - - - - - -
IL1RN - −2.02 −2.97 - −3.56 - - - 4.26
IL8RB −2.96 - - - 2.73 - 3.42 -
Table 2 Differentially regulated inflammatory genes in
MDMs infected with HIV-1 ΔVpr compared to mock/
uninfected (N=6)
Genes Day1 Day2 Day3 Day4 Day8 Day12 Day16 Day20
CD40LG - - - - 2.68 7.36 - -
IFNA2 −2.95 - −2.24 - - 9.72 - -
IL10 2.11 - - - - - - -
IL13 - - - −2.18 −2.01 14.11 - -
IL17C - - - - - 3.29 - -
IL1A 7.73 7.74 2.088 - - - - -
IL1B 71.73 50.57 10.30 2.75 −2.17 - - -
IL1F10 - - - - - 5.34 - 3.79
IL22 3.44 - - - −2.63 4.96 −3.70 2.30
IL5 - - - - - 5.31 2.49 -
IL8 23.79 16.27 6.30 2.61 - - - -
IL9 - −2.74 - - - 5.32 - −5.33
LTA - - 2.53 - - 3.82 −3.04 2.88
TNF 3.86 2.46 - - - - - 2.6
IL10RA - 2.45 - −2.02 - - - -
IL10RB - - - - - - - −2.82
IL9R - - −2.14 2.95 - 5.76 - 2.84
IL13RA1 - - - - - - - -
IL5RA - - −2.71 - −3.76 10.24 2.15 5.06
BCL6 3.24 4.27 2.26 2.67 - - - 2.40
C3 8.51 9.88 5.38 2.22 −2.04 −10.82 −4.36 -
C4A - - - - - - - 2.34
CEBPB - - - - - - - 6.26
CRP - - - - 13.47 −4.63 -
IL1RN - - - −2.31 - - - -
IL8RB −2.96 - - - - - - -
LTB4R - - - - 2.35 - - -
TOLLIP −2.01 - - - - - 2.29
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transcript levels, absence of Vpr also reduced the release
of IL-1β, IL-8 and TNF-α compared to HIV-1wt-infected
MDMs. The concentrations of IL-1β and IL-8 were sig-
nificantly (P= 0.045 for IL-1β at day 16; P= 0.0257 and
P= 0.010 for IL-8 at day 12 and 20 respectively) higher
in wild type-infected compared with ΔVpr-infected cul-
ture at infection phase (Figure 2A). The increase and/or
decrease in protein levels were directly correlated with
the RNA transcript levels. Figure 2B represents one of
six individual experiments demonstrating the correl-
ation. For instance, IL-1β and TNF-α showed a decrease
on day 8 both at the protein and transcript levels fol-
lowed by a reduction on day 12 compared to HIV-1wt-
infected culture.
Absence of Vpr reduces activation of p38 and SAPK/JNK
and not ERK1/2 in MDMs
MAPK signaling cascade is known to play a role in the
production of cytokine/chemokine by macrophages/
microglia and astrocytes and hence activate immune re-
sponse in the host cells [19,32,33]. Therefore, next we
examined whether deletion of Vpr could modulate phos-
phorylation of the three most important members of
MAPK family including ERK1/2, p38 and SAPK/JNK
that are known to regulate proinflammatory cytokine
production. Phosphorylation of ERK1/2, p38 and SAPK/
JNK was assessed by western blot from 6 hours to
20 days post infection after activating the MDMs with
LPS and the bands were quantified by densitometry
(Figure 3A, B). Results indicate an increase in phosphor-
ylation of p38, SAPK/JNK and ERK1/2 at 6 hours post
infection in both HIV-1wt and HIV-1ΔVpr-infected
MDMs compared to control (data not shown). This in-
crease was followed by a decrease at 12, 24 and 36
hours. Phosphorylation of MAPKs at 6 hours may be the
consequence of gp120 binding and Vpr may not have
specific effect at this stage. The difference of phosphoryl-
ation levels of p38 and SAPK/JNK between HIV-1wt and
HIV-1ΔVpr-infected MDMs was first observed at 48
hours post infection and was maintained up to day 8.
Phosphorylation of SAPK/JNK was most pronounced at
day 8. However, ERK1/2 showed no change in phosphor-
ylation between HIV-1wt and HIV-1ΔVpr-infected
MDMs over a period of 20 days except the initial expos-
ure (6 hours post infection).
To confirm the involvement of p38 and SAPK/JNK
signaling molecules and to cross check the effect of
ERK1/2 on IL-1β, IL-8 and TNF-α upregulation, MDMs
were pretreated with SB203580, SP600125 and PD98059
prior to infection with HIV-1wt or HIV-1ΔVpr or mock.
Supernatants were collected 48 hours post infection and
the concentrations of TNF-α, IL-1β and IL-8 by ELISA
were measured (Figure 3C) in multiple donors (N = 3).
MAPK inhibitors reduced the levels of all tested proin-
flammatory factors in all infected MDM supernatants
compared to control MDMs. Blocking of ERK1/2 path-
way with PD98059 showed reduction in IL-1β, IL-8 and
TNF-α levels in both infected and uninfected MDM
supernatants. However, SB203580, that blocks p38 path-
way, significantly suppressed the production of IL-1β as
well as IL-8 in HIV-1wt-infected MDMs compared to
HIV-1ΔVpr-infected culture suggesting that activation of
p38 pathway is involved in production of IL-1β and IL-8
in MDMs. However, SB203580 did not exhibit any spe-
cific difference in TNF-α level between HIV-1wt and
HIV-1ΔVpr virus-infected MDM cultures indicating that
Vpr-induced TNF-α production could be mediated by
other pathways. Pretreatment of MDM culture with
SP600125, a selective inhibitor of JNK, specifically
Table 3 Differentially regulated inflammatory genes in
MDMs infected with HIV-1 ΔVpr compared to HIV-1wt
(N= 6)
Genes Day1 Day2 Day3 Day4 Day8 Day12 Day16 Day20
CD40LG - - - - - - - 2.37
IFNA2 - - - - - 3.05 - -
IL10 - - - - - - - −2.94
IL13 - - - - - 4.20 - -
IL1A - - - - - −2.015 −2.12 −2.53
IL1B - - 2.135 - −3.149 −4.84 −4.76 −4.19
ILF10 - - - - - 2.75 - -
IL22 - - - - - 4.67 −3.21 -
IL36A - - - - - 3.55 - -
IL36B - - - - - 3.228 - -
IL36G - - 2.09 - 2.004 - - −2.27
IL5 - - - - - - - −2.05
IL8 - - - - −2.62 - 2.62 −3.64 −3.27
IL9 - – - - - - - 2.12
LTA - - - - - - −2.24 -
TNF - - - - - −2.41 - -
IL1RN - - - - - - - 2.35
IL5RA - - - - - 6.18 - 3.44
IL9R - - - 2.661 - 5.05 - -
Table 4 Differential expression of inflammatory factors in
HIV-1ΔVpr-infected MDMs compared to HIV-1wt-infected
(N= 6) including all time points
Gene symbol Fold change p-value
IL5RA 2.091 0.269
XCR1 2.046 0.974
IL1β −4.178 0.033
IL8 −2.997 0.036
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reduced the HIV-1wt-infected MDM-derived IL-8 pro-
duction compared to mock treated or HIV-1ΔVpr-
infected culture suggesting the association of SAPK/JNK
pathway with IL-8 production in MDMs. No specific
differential expression pattern was observed for IL-1β
and TNF-α with SP600125 in presence or absence of
Vpr. These results suggest that p38 and SAPK/JNK but
not ERK1/2 are involved in IL-1β and IL-8 production.
Figure 2 HIV-1ΔVpr produces less proinflammatory IL-1β, IL-8 and TNF-α in MDMs than HIV-1wt. MDMs were infected with HIV-1wt or
HIV-1ΔVpr virus at an MOI of 0.1 or left untreated for 1, 2, 3, 4, 8, 12, 16 and 20 days. (a) Expression of IL-1β, IL-8 and TNF-α in protein levels in
supernatants of HIV-1wt, HIV-1ΔVpr and mock-infected (NT) MDMs collected at indicated time points was monitored by ELISA (N = 6). Absence of
Vpr reduced the production of proinflammatory cytokines. The results presented are the mean concentration of cytokines ± SEM. *P < 0.05 (two
tailed student’s t-test) compared to HIV-1ΔVpr-infected cultures. (b) qRT-PCR was carried out with the cell lysates as mentioned in Methods
(N= 6). RNA fold changes were compared with ELISA data for each individual experiment. The expression of cytokines in protein levels (HIV-1wt;
red lines and HIV-1ΔVpr; blue lines) was correlated with the respective RNA transcripts (fold changes in HIV-1wt compared to HIV-1ΔVpr; green
lines). Figure represents one of six independent experiments.
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HIV-1ΔVpr activates these MAPKs to a less extent and
hence induces less production of proinflammatory cyto-
kines compared to HIV-1wt.
Absence of Vpr reduces neuronal death in part through
proinflammatory cytokines
To obtain primary neurons for toxicity studies, NP cells
were differentiated as described in Methods and con-
firmed by immunostaining using specific markers. One
week post-differentiation the cells exhibited neuronal
phenotype followed by increased expression of neuronal
markers, MAP2 or β-III tubulin. Expression of MAP2 or
β-III tubulin positive cell population increased to ap-
proximately 80% 2 weeks post differentiation (Figure 4).
Astrocyte contamination was verified by immunostain-
ing the cells using antibody against GFAP and results in-
dicate absence of astrocytes in our cultures.
Infected target cells in CNS compartment are known to
dysregulate neuronal function and survival through proin-
flammatory factors [9,34,35]. To investigate the role of
Figure 3 HIV-1ΔVpr does not activate p38 and SAPK/JNK in MDMs as HIV-1wt. MDMs infected with HIV-1wt, HIV-1ΔVpr or mock (NT) were
activated with 1 μg/ml of LPS for 4 hours and the cells were harvested at 6, 12, 24, 48 hours, 4, 8, 12 days. (a) Cells were lysed and 50 μg of
protein of each sample was analyzed by western blot using antibodies against the active and total form of ERK1/2, p38 and antibodies against
SAPK/JNK and tubulin. (b) Relative band intensities of phosphorylated products were normalized with total proteins. Densitometrical
quantification of western blot data represents the ± SEM of three independent observations. *P < 0.05 (two tailed student’s t-test) compared to
HIV-1ΔVpr-infected cultures. (c) MDMs were preincubated with PD98059 (10 μM), SB203580 (10 μM) and SP600125 (10 μM) for 2 hours and then
infected with HIV-1wt or HIV-1ΔVpr virus at an MOI of 0.1 or mock. After 48 hours of infection IL-1β, IL-8 and TNF-α ELISA were performed. MDMs
without MAPK inhibitors were considered to be the control and were reused to normalize other results. Each sample was run in triplicates, the
results are ± SEM of the concentration of the cytokines and *P < 0.05 compared with HIV-1 ΔVpr treated.
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proinflammatory factors in inducing neuronal death, pri-
mary neurons were exposed to different amounts of cul-
ture supernatants from HIV-1wt, HIV-1ΔVpr and mock-
infected MDMs (5%, 10%, 20% v/v in culture media).
Supernatants from day 8 and day 12 were used, as IL-1β,
IL-8 and TNF-α concentrations were highest at these time
points. Neuronal death (%) was assessed 24 to 48 hours
post treatment by Annexin-V staining. Recombinant pro-
teins, rhIL-1β, rhIL-8 and rhTNF-α were used in parallel
as positive controls. When neurons were exposed to dif-
ferent concentrations of MDM supernatants no difference
in cell viability was observed at a concentration of 5%
(v/v) exposure, whereas 10% (v/v) supernatant induced
differential cell death and this effect tapered off with in-
creasing concentration (data not shown). Hence all the
experiments were performed with 10% MDM superna-
tants to assess neurotoxicity. Supernatant from mock-
treated neurons exhibited approximately 11% cell death as
basal level apoptosis, whereas neuronal culture exposed to
HIV-1wt or HIV-1ΔVpr-infected supernatant, exhibited
approximately 25% (P= 0.0078) and approximately 17%,
(P= 0.0349) cell death respectively. HIV-1ΔVpr-infected
MDM supernatant resulted in significantly (P= 0.0481)
lower neuronal death compared to HIV-1wt. Interestingly,
the recombinant proteins rhIL-1β (approximately 27%)
and rhIL-8 (approximately 24%) and not rhTNF-α (ap-
proximately 14%) exhibited similar significant cell death
(Figure 5A).
To confirm this result, neuronal survival was also exam-
ined by MTT assay, which exhibited significantly reduced
neuronal survival with HIV-1wt (73%; P= 0.0139) but not
with HIV-1ΔVpr (84%; P= 0.0669)-infected MDM super-
natant compared to control. HIV-1ΔVpr-infected MDM
supernatant further reduced the neurotoxic effect of the
virus significantly (P= 0.0439) compared to HIV-1wt
(Figure 5B). Treatment of neurons with recombinant pro-
teins, rhIL-1β, rhIL-8 and rhTNF-α exhibited 63%, 78%
and 87% cell survival respectively, confirming their role in
neuronal apoptosis.
Induction of apoptosis via death receptors activates
initiator caspases, which in turn activate effector cas-
pases 3 and 7. To investigate whether caspase 3/7 path-
way is involved in inducing neuronal apoptosis neurons
were pretreated with MDM supernatants (day 8 and 12)
or recombinant proteins, for 24 hours and Caspase-
GloW 3/7 assay was performed. Exposure of neurons to
HIV-1wt-infected MDM supernatants significantly in-
creased caspase 3/7 activity compared to untreated or
HIV-1ΔVpr-infected MDM supernatant (Figure 5C).
Compared to mock-infected supernatant, HIV-1ΔVpr
Figure 4 Differentiation of NP cells to primary neurons. Differentiation of the NP cells to primary neurons was performed for 2 weeks.
Neuronal differentiation was confirmed by immunostaining. Neurons were fixed, permeabilized and stained with neuronal marker MAP2 (green)
and β-III tubulin (green) or astrocyte specific marker GFAP (red). Nuclei were stained with Hoechst 33342 (blue). The figures are representatives of
one of three independent experiments.
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virus-infected supernatant exposure induced approxi-
mately 2-fold higher caspase 3/7 activity, whereas, HIV-
1wt virus-infected supernatant showed approximately 3-
fold increased caspase 3/7 activity in neurons. Activation
of caspase 3/7 in neuronal culture treated with recom-
binant proteins confirmed their role in neuronal apop-
tosis. Although rhIL-1β induced the highest activation
(approximately 3-fold), rhIL-8 (approximately 2.5-fold)
Figure 5 HIV-1-induced neuronal death is mediated in part through IL-1β and IL-8 and not TNF-α present in supernatants of
HIV-1wt virus-infected MDMs. Primary neurons exposed to HIV-1wt, HIV-1ΔVpr and mock-infected (NT) MDM supernatants (10% v/v) as well as
recombinant IL-1β (10 ng/ml), IL-8 (10 ng/ml) and TNF-α (100 ng/ml) for 24 – 48 hours were analyzed for neuronal apoptosis by (a) Annexin-V
FITC staining, nuclei of the cells were stained with Hoechst 33342 and measured the neuronal death (%); (b) MTT assay, absorbance was
measured and cell viability was normalized with negative controls. HIV-1wt-infected MDM supernatants were more neurotoxic compared to
HIV-1ΔVpr culture. (c) The cells were lysed in Caspase-GloW 3/7 substrate and protease activity was measured as relative light units (RLU).
(d) Neurons were lysed and 50 μg of protein for each sample was analyzed by western blot using specific antibodies for cleaved and total PARP.
(e) Neurons exposed to supernatants from HIV-1wt, HIV-1ΔVpr and mock-infected MDM (NT) were treated with and without anti-IL-1β, anti-IL-8
and anti-TNF-α and neurotoxicity was analyzed after 24–48 hours by Annexin-V staining. Results are the ± SEM of three individual experiments;
*P < 0.05, **P < 0.01 in HIV-1wt compared with control or HIV-1 ΔVpr treated.
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also significantly enhanced the caspase 3/7 levels in neu-
rons. Compared to control, caspase 3/7 activity caused
by rhTNF-α was <2-fold higher, which was much less
compared to other recombinant proteins.
Furthermore, impaired activation of caspase 3/7 was
also reflected in PARP expression in neurons. PARP, cat-
alyzed by cleaved caspase 3 and 7, is the end product of
caspase cascade and functions as a DNA-binding en-
zyme that detects DNA strand break [36,37]. Western
blot results further confirmed that absence of Vpr
induced a decreased level of cleaved PARP (c-PARP) in
HIV-1ΔVpr-infected MDM supernatants-treated neu-
rons compared to its HIV-1wt counterpart (Figure 5D).
Similarly, recombinant cytokines showed increased c-
PARP signals in neuronal culture confirming their asso-
ciation with neuronal apoptosis. This result indicates
that IL-1β, IL-8 and TNF-α might play a role either dir-
ectly or by networking with some other downstream fac-
tors that in turn can activate neuronal death through
caspase pathway.
Neutralization of IL-1β and IL-8 protects neuronal death
To confirm that the neuroprotective effect of Vpr-
deleted virus is mediated through proinflammatory fac-
tors released by MDMs, neurons were exposed to HIV-
1wt, HIV-1ΔVpr and mock-infected MDM supernatants
with or without IL-1β, IL-8 and TNF-α-neutralizing
antibodies or isotype controls for 24 hours and neuronal
apoptosis was determined by Annexin-V staining.
Results showed that pre or post incubation of neurons
with anti-IL-1β and anti-IL-8 antibodies restored 38%
and 22% neuronal death in HIV-1wt MDM supernatant-
treated cultures, respectively whereas anti-TNF-α anti-
body had no significant effect (4%) in protecting HIV-
1wt MDM supernatant-induced cell death (Figure 5E).
Interestingly, in HIV-1ΔVpr-infected MDM culture, al-
though neutralizing antibodies also reduced neuronal
death the effects were not significant. Collectively, these
results confirm the role of Vpr-mediated indirect effect
on neuronal survival via proinflammatory cytokines.
Discussion
Neuroinflammation in the context of viral infections in-
cluding HIV-1 could result from the following scenarios.
First, the infiltration of infected monocytes/macrophages
and lymphocytes from the periphery into CNS compart-
ment; second, the release of viral and cellular factors by
the infiltrated cells; third, the infection of resident
macrophages/microglia by HIV-1 entering CNS or
through virus released from the infiltrated cells. The
infiltrated monocytes and lymphocytes are the key
players of proinflammatory cytokines production [38,39].
The infected target cells are also known to secrete viral
proteins including gp120, Tat, and Vpr, which are known
to alter proinflammatory milieu in brain [24,40,41]. The
role of gp120 and Tat in modulating proinflammatory
cytokines and hence the effect on neurodegeneration has
been studied extensively [16,42,43]. Few studies have
also documented HIV-1 Vpr-mediated neuropathogen-
esis [24,44], however, effect of Vpr on neurotoxicity
through proinflammatory cytokines remains undefined.
HIV-1 Vpr has several features that may facilitate its role
as a player in neuropathogenesis. Vpr, as a late viral pro-
tein synthesized in the infected cells, is released from
the infected cells and is also taken up by nearby cells.
Hence, the ability to cause damage is not confined to
only virus-infected cells. Another interesting feature is
that Vpr is also incorporated into the virus particles.
This enables Vpr to be transferred to cells upon infec-
tion by the virus. It should be noted that virus particles,
both in the infected individual and in cell culture, com-
prise a high proportion of non-infectious in comparison
to infectious particles. Although non-infectious virus
particles are replication defective, they are still capable
of transferring viral proteins such as Vpr into target
cells. This shows that Vpr can cause damage through
multiple avenues. In an effort to analyze the effect, pre-
vious studies focused on using specific viral proteins
(purified recombinant proteins) in the absence of other
viral proteins. Although these studies provided some
insight, unfortunately the concentrations used are in the
non-physiological range. This is the basis for our studies
aimed at investigating the indirect effect of Vpr deletion
on protection from neuronal damage (in comparison to
HIV-1wt) through proinflammatory cytokine network
using replication competent HIV-1wt and HIV-1ΔVpr-
infected MDMs.
Expression of proinflammatory cytokines was upregu-
lated in HIV-1wt-infected MDMs compared to controls
at the transcriptional level. In Vpr-deleted virus-infected
culture, most of the proinflammatory cytokine genes
were upregulated only in the first four days when com-
pared with mock. The increased expression of these
cytokines immediately upon infection and not at the in-
fection phase could be an immediate effect of HIV-1 en-
velope protein binding to cell surface receptors or may
be indicative of less HIV-1ΔVpr virus infectivity in
MDMs at later time points. Compared to HIV-1wt, HIV-
1 ΔVpr-infected MDMs exhibited downregulation of IL-
1β and IL-8 four days post infection and maintained the
low level up to day 20. Lower expression of TNF-α was
also observed at protein level in HIV-1ΔVpr culture
compared to HIV-1wt, although no significant difference
was found in transcriptional level.
Deletion of Vpr-suppressed IL-1β, IL-8 and TNF-α pro-
duction in MDMs suggests that Vpr plays a role in the
production of these cytokines. However, it is not clear
whether Vpr specifically regulates these cytokines directly
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through transcriptional regulation or by enhanced MDM
infection [45]. It has been shown that Vpr either as a
virion-associated molecule or as a free protein is known to
act as a transcriptional regulator [46-48]. Our preliminary
bioinformatics analyses (data not shown) indicate the
presence of several common transcription factor-binding
sites present in IL-8 and IL-1β promoters suggesting that
they could be potentially involved in increased expression
of these genes. However, many of these sites are also
shared by other cytokines such as TNF-α (four common
in all three) suggesting that Vpr might utilize these tran-
scription factors to upregulate these cytokines in an addi-
tive manner. In-depth chip-based analyses are required to
address these questions, which is beyond the scope of this
manuscript. Alternatively, the coincidence of decreased
HIV-1 replication with decrease of IL-1β, IL-8 and
TNF-α levels in HIV-1 ΔVpr-infected MDMs with
time indicates virus replication could also be one of
the major determinants of increased expression of
proinflammatory factors [45].
IL-1β and TNF-α have a broad range of similar and
complex physiological effects including their ability to
induce expression of a number of genes depending on
the cell lineage. These two cytokines stimulate the pro-
duction of chemotactic factors such as IL-8 in cells of
CNS [49]. Hence, it is possible to speculate that IL-8
downregulation in HIV-1ΔVpr-infected MDMs may be a
consequence of decreased levels of IL-1β and TNF-α
compared to HIV-1wt-infected culture.
Expression of the proinflammatory factors in HIV-1
disease can be partly explained through the influence of
HIV-1 on signaling pathways. Although HIV-1 interacts
with several signaling molecules, in this study we fo-
cused on MAPK because these kinases are involved in
many cellular activities including activation, prolifera-
tion, differentiation, survival and cytokine production
[50-52]. Furthermore, signaling pathways controlling IL-
1β, IL-8 and TNF-α gene expression have been linked to
MAPK [53,54]. Several viral proteins such as gp120, Nef
and Tat are known to interact with MAPK pathways
[55-57]. Hence, we investigated if deletion of Vpr could
suppress activation of MAPK pathways in MDMs; that
could indicate indirectly the involvement of MAPKs in
Vpr-induced differential regulation of proinflammatory
cytokines. We observed decreased activation of p38 and
SAPK/JNK in HIV-1ΔVpr compared to HIV-1wt-infected
MDMs stimulated with LPS. Studies have shown that
gp120 activates p38 during early phase of exposure/in-
fection via chemokine and HIV-1 co-receptors binding
[58]. However, it is unclear how phosphorylation p38
and SAPK/JNK are associated with the proinflammatory
cytokine production in MDM. One explanation could be
that activation of these signaling molecules may phos-
phorylate and/or translocate transcription factors that
may activate promoters of IL-1β and IL-8 and upregu-
late gene expression. In the current study phosphoryl-
ation of ERK1/2 was not enhanced in response to
infection, which is quite similar to an early study where
the authors showed that Vpr induces cell cycle arrest
through downregulation of ERK pathway rather than
change in phosphorylation status [59].
Although HIV-1 does not infect neurons directly, the
cytopathic effects on neurons are probably caused by
macrophage/microglia-derived proinflammatory cytokines.
The neurotoxic and proinflammatory cytokines implicated
in HAND pathogenesis are IL-1β and TNF-α [12,14]. These
factors have been reported to increase the permeability of
blood–brain barrier and also over stimulate NMDA recep-
tors, which cause lethal neuronal increase in Ca2+ levels
[60]. IL-8 also could function as a mediator of neuronal
death via its effects on release of neurotoxins such as
matrix metalloproteinase as well as by induction of cell
cycle and pro-apoptotic proteins [61]. A recent study re-
ported that IL-8 levels in CSF of HAND patients are higher
compared to HIV-1 seropositive patients without neuro-
logical disorders [19]. HIV-1 gp120 and Vpr-induced in-
crease in IL-8 production in CNS is reported [62,63].
Suppression of production of these neurotoxic proinflam-
matory cytokines could be a possible way to reduce risk of
neuronal apoptosis. In our study, deletion of Vpr caused
significant reduction of proinflammatory cytokine IL-1β,
IL-8 and TNF-α production, coinciding with the viral repli-
cation. This suggests that Vpr has both direct and indirect
effects on the cytokine production. The exact mechanism
of Vpr in neuropathogenesis is not prominent, although it
is known to activate both intrinsic and extrinsic pathways.
Soluble Vpr causes neuronal apoptosis, involving cyto-
chrome c extravasation and p53 induction [44]. Our results
on neuronal apoptosis and effector caspase activation upon
exposure to HIV-1wt-infected MDM supernatants showed
increased caspase-mediated neuronal death suggesting that
soluble factors present in these cultures are responsible for
neuronal death. This result is consistent with other studies,
which also demonstrated increased caspase activation in
presence of rVpr [44,64]. However, this does not delineate
whether the soluble viral proteins and/or cellular factors
present in MDM supernatant are responsible for neuronal
damage. Results of partial restoration of neuronal death in
presence of neutralizing antibodies against IL1β and IL-8
suggest that HIV-1 Vpr-induced IL-1β and IL-8 could pos-
sibly be the two important factors that affect neuronal
apoptosis. Previous studies showed that administration of
rhIL-1β enhances ischemic brain edema formation, size of
the brain infarction, increases neuronal death, whereas, ad-
ministration of anti–IL-1β reverses the neuronal death
in rat model [65]. Compared to an HIV-1 positive pa-
tient without neurological disorder, HAND patients
have increased levels of IL-8, the production of which
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is probably induced by IL-1β and TNF-α through
MAPK pathways [19].
Conclusion
Overall, our results demonstrate that HIV-1 Vpr plays
an important role in MDM infection as well as produc-
tion of proinflammatory and neurotoxic cytokines IL-1β
and IL-8 by infected/exposed MDMs. These cytokines
have already been reported to be associated with preva-
lence, frequency and severity of neurological disorders.
Currently, different studies are in progress focusing on
targeting cytokines as a therapeutic strategy for treat-
ment of neurocognitive diseases. Deletion or alteration
of Vpr reduces the production of proinflammatory cyto-
kines and partially rescues neurons from cell death, thus
targeting HIV-1 Vpr could be one possible approach to
reduce the risk of HAND.
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